A holistic metabolic disease management start-up, Dia Beta Labs Ltd has been named the overall winner of the 2024 INVENT Awards, after securing top spot of the brand new BioBreakthrough category.
Organised by science and technology hub Catalyst with headline partner Bank of Ireland UK, INVENT an event created for early-stage start-ups and aspiring entrepreneurs to showcase their innovations to a panel of expert judges.
At an award ceremony held in the ICC Belfast on Thursday 3 October 2024, twelve finalists competed for the main prize, with Dia Beta Labs Ltd triumphing overall and taking home £25,000 from the total prize fund of £55,000.
Each category winner took home £5,000.
Dia Beta Labs Ltd describes itself as an innovative and future-thinking company, developing transformative treatments which take a holistic approach to metabolic disease management.
These treatments aim to provide high-quality, sustainable weight loss through preferential targeting of fat whilst sparing muscle.
Additionally, they rescue insulin-producing cells of the pancreas which are lost over time as the …